Asia-Pacific Digital Respiratory Device Market Player Analysis and Growth Opportunities

Asia-Pacific Digital Respiratory Device Market Projected to Expand at 36.2% CAGR Through 2028

The Asia-Pacific Digital Respiratory Device Market is projected to grow at a CAGR of around 36.2% during the forecast period, i.e., 2023-28. Most of the market expansion attributes to the mounting instances of respiratory diseases, including asthma, chronic obstructive pulmonary disease, and sleep apnea resulting in the frequent adoption of the digital technology-enabled medical device. Besides, the region’s widespread presence of other respiratory diseases, such as chronic bronchitis, emphysema, and wheezing, has swiftly augmented the demand for digital respiratory devices. For instance, per the research study titled” Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modeling study”, South East Asia Region had the most significant global cases of current wheezing, with 200.57million in 2019, The age group that contributed the most was 30-34 years in West Pacific region. The countries with the most cases of current wheezing globally were China and India.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/asia-pacific-digital-respiratory-device-market.html

Strategic Takeaways from the Report:

Market Sizing and Forecasting
Regulatory and Policy Influence
Competitive Trends and M&A Activity
Innovation Drivers and Disruptive Technologies
Investment Hotspots and Emerging Niches
Geographical Dynamics and Trade Flows

Asia-Pacific Digital Respiratory Device Market Segment Overview & Classification

This market is categorized to offer targeted insights across various operational and consumer-related verticals.

Segment List:

By Device Type

Therapeutic Devices
- CPAP Devices
- BI-PAP Devices
- Humidifiers
- Nebulizers
- Ventilators
- Inhalers
- Oxygen Concentrates
- Resuscitators
Diagnostics Monitoring Devices
- Spirometers
- Pulse Oximeters
Consumables and Accessories
Respiratory Therapy Wearable Medical Device
- Watch and Wristband
Disposables
- Nasal Cannulas
- Filters
- Breathing Circuits

By End-User

Homecare
Hospitals and Clinics
Ambulatory Care Centers

All things considered, Hospitals & Clinics acquired a sizeable portion of the Asia-Pacific Digital Respiratory Device Market and are projected to continue to lead in the same direction over the coming years. This growth ascribes to a rapid increase in the elderly population, which has subsequently elevated the demand for emergency and long-term hospitalizations.

By Application

Chronic Obstructive Pulmonary Disease
Sleep Apnea
Asthma
Infectious Disease

By Country

China
India
Japan
Australia
New Zealand
South Korea
Rest of Asia-Pacific.

Country-wise, China garnered the lion’s share of the Digital Respiratory Device Market across Asia Pacific in the historical period. The outbreak of Covid -19 and the ever-increasing aging population have been the prominent factors backing the steady adoption of such devices here. It also owes to the growing prevalence of asthma, which has been an economic and social burden for children and guardians for the past three decades. As such, China announced its first health initiative, Healthy China 2030, which seeks to improve the national health system. Such initiatives would further propel the demand for smart and effective medical devices in the long run. Moreover, Medical informatics research in China has AI as a competing arena focusing on diagnostic deep-learning algorithms for medical imaging.

These divisions help clarify demand patterns and expected shifts.

Market Opportunities

Increasing Prevalence of Chronic Respiratory Diseases Across APAC - COVID-19 came as a shock to the economies in the APAC region as the healthcare infrastructure was not comparable to the global benchmarks. This outbreak ultimately resulted in an increased number of patients suffering from respiratory ailments. China has the most significant number of chronic obstructive pulmonary disease incidences due to the rising aging population. As of Jan 2020, around 41.3% population in China were aged over 60 years of age, says United Nations (UN). Owing to alarming levels of air pollution, exposure to chemicals, an aging population, and rising smoking habit among inhabitants, the rate of frequency of diseases such as chronic pulmonary diseases (COPD) and asthma is growing among the people in the region. Such increasing prevalence of diseases would positively influence the supplies of respiratory devices in the forecast period.

Asia-Pacific Digital Respiratory Device Market Competitive Snapshot from 2023-2028

The report highlights established and emerging players in the global Asia-Pacific Digital Respiratory Device Market, evaluating their strengths, challenges, and potential for innovation.

Key Competitors Include:

Philips
3M Healthcare
Astra Zenca Plc.
Novartis AG
GE Healthcare
Masimo Corporation
Cipla Ltd.
Resmed Ltd.
Teva Pharmaceuticals Industries Ltd.
Acorda Therapeutics.

Their activities include partnerships, product launches, and geographic expansions.

Asia-Pacific Digital Respiratory Device Industry Trends

The Outbreak of Covid-19 Prompting the Utmost Utilization of Digital Respiratory Devices - The sudden breakout of the pandemic in China and its spillover to other Asia-Pacific countries has increased the demand for Digital Respiratory Medical Devices exponentially. As such, the rise in the death toll and the number of infected individuals has pushed governments and private healthcare players toward adopting more sophisticated respiratory medical devices to detect, prevent and monitor such viral pandemics. Therefore, the demand is expected to proliferate in the forthcoming years as precautionary healthcare spending in various countries is likely to snowball considerably.

Frequently Asked Questions (FAQs):

What industries are most impacted by this market?
How is technology reshaping operations and offerings?
Which competitors dominate the landscape?
What risks could disrupt market expansion?
How should businesses respond to demand fluctuations?

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Other Report:

Note: If you need additional information not included in the report, we can customize it to suit your requirements. https://www.marknteladvisors.com/query/request-customization/asia-pacific-digital-respiratory-device-market.html

Why Trust MarkNtel Advisors?

In-depth primary and secondary data validation
Focused on practical insights, not just raw numbers
Designed to support business strategy, not just reporting
Strong industry connections and real-time data flow
Transparent methodology and reliable sourcing

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India